Navigation Links
Survey Results Show Long-Term Care Providers Wary about Healthcare Reform
Date:6/11/2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Survey Results Show Long-Term Care Providers Wary about Healthcare Reform 
Survey Results Show Long-Term Care Providers Wary about Healthcare Reform
(Date:12/16/2009)... 16 The most widely used human embryonic stem ... social justice questions that must be addressed to ensure ... advances, according to a University of Michigan research team. ... the U-M team analyzed 47 embryonic stem cell lines, ... cell researchers. The scientists determined the genetic ancestry of ...
(Date:12/16/2009)... susceptibility to disease , , WEDNESDAY, Dec. 16 (HealthDay ... to leprosy have been identified by scientists in ... more than 10,000 DNA samples from leprosy patients ... highlights the important role that the innate immune ... "Though leprosy is not common, the discoveries have ...
(Date:12/16/2009)... at work on a malaria elimination study in Africa ... the disease using cell phone records. , The scientists ... often residents of Zanzibar travel and where they go. ... coast of Tanzania in East Africa, Zanzibar has drastically ... study as part of deliberations on whether to launch ...
(Date:12/16/2009)... time in half, but use in humans is still far ... improve on nature, researchers have built and tested synthetic versions ... trauma or other cases where blood just won,t stop flowing. ... is used in degradable stitches, which dissolve in the body," ... Case Western Reserve University, and lead author of a report ...
(Date:12/16/2009)... marketing campaign , ... Englewood, CO ... Genetown™ Hotbed Campaign as its largest yearly promotion for ... MassBio and showcases 37 Massachusetts companies across biotechnology, ... brand on an electronic and printed map that ...
Breaking Medicine News(10 mins):Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Leprosy Genes Identified 2Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:Thriving Bioscience Region Leaves Its Mark 2
... cancer treatment might cause a cancer revolution is available ... radioactive microspheres.// ,Pioneered by an Australian, this ... patients who develop secondary liver cancer but is expected ... previously available only to patients in clinical trials who ...
... fertility problems can now be hopeful for Dekel and a research ... //that could have a role, in the placement of the fertilized ... taken at several stages in the menstrual cycles of 12 women ... check if the levels of the protein were altered during the ...
... Thun of the American Cancer Society it was found that death ... On the other hand men who never smoked had higher lung ... million Americans. Lung cancer is by far the biggest cancer killer ... in the United States alone. ,This report is contradicting ...
... outlined programs to ease bureaucratic procedures in the department. // ... by the minister in Launceston this morning to 200 of ... is to reduce the number of approvals needed for day-to-day ... within the bureaucratic process and we're addressing those,’ she said. ...
... induced by oxygen free radicals may be one important ... //This groundbreaking study conducted by neuroscientists at the University ... I, a protein that plays a major role in ... blamed for cellular damage in Parkinson’s disease. ...
... disorder which completely affects the immune system. In case ... was successfully used to cure this life threatening disease. ... Veterinary Medicine and the National Institute of Allergy and ... a vector for the correct gene of XSCID. ...
Other Medicine News:Health News:A Revolutionary New Treatment For Cancer Available In Australia 2Health News:Oxygen-Induced Damage A Leading Cause For Parkinson’s Diseas 2Health News:In-Vivo Gene Therapy Technique to Cure XSCID in Basset Pups 2Health News:In-Vivo Gene Therapy Technique to Cure XSCID in Basset Pups 3
(Date:12/16/2009)... Greenway Medical Technologies, Inc. today announced that its ... management and interoperability solution, Prime Suite® 2011, ... annual 2009 Top 20 Best in KLAS ... ,, For practices having between six and 25 ... in KLAS in ambulatory EMR for the fourth ...
(Date:12/16/2009)... -- Today, Avantium announced the,appointment of Gunnar ... pharmaceutical,business. Gunnar Staaf previously worked at Serentis ... Company, in a range of commercial and ... in Avantium,s plan to,spin-out its pharmaceutical business. ... company based on its offering of proprietary,crystallization ...
(Date:12/16/2009)... 16 CVS/pharmacy and MinuteClinic health care ... offering H1N1 vaccine in 20 states and Washington, ... for receiving H1N1 vaccines continue, many states have ... to receive the shot while supplies last. ... and is available at MinuteClinic locations across the ...
Breaking Medicine Technology:Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 2Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 3Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards 4Avantium Appoints Gunnar Staaf as CEO Pharma 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4SIUE School of Pharmacy Launches Collaborative Site for Pain Palliative Care Pharmacy 58620 1SIUE School of Pharmacy Launches Collaborative Site for Pain Palliative Care Pharmacy 58620 2SIUE School of Pharmacy Launches Collaborative Site for Pain Palliative Care Pharmacy 58620 3OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 1OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 2OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 3OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 4OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 5LA BioMed study finds higher survival rate among intoxicated trauma patients 58613 1
... WORCESTER, Mass.--(BUSINESS WIRE)--Jun 28, 2007 - Biovest,International, Inc. ... Inc. (NASDAQ:ABPI), announced on June,27, 2007 blinded interim ... 3 clinical trial of BiovaxID(TM) for Non-Hodgkin's,lymphoma (NHL) ... data is the most recent data that has ...
... Incidence of Recurrent Wheeze by,Almost Half, ABBOTT ... 2007,/PRNewswire-FirstCall/ -- Abbott and MedImmune today announced,results ... July issue of Journal of,Pediatrics, showing that ... in premature infants by almost,half. , Specifically, ...
Other Medicine Technology:Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable,Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical,Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma 2Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable,Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical,Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma 3Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable,Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical,Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma 4Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable,Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical,Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma 5New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5
... Introduction of the Selenia full ... beginning of a new era in ... of elegance and innovation combines the ... with sophisticated information management capabilities to ...
... new concept in pupillometry, designed around the highly ... for the P2000. We have now defined ... paid particular attention to the visual illumination and ... extremely flexible, allowing you to elicit and measure ...
... Dr. George Ojemann at the University ... is the industry standard for cortical ... current unit has simple, uncomplicated controls ... in the awake or anesthetized patient. ...
... strip electrodes are extra thin and ... a burr hole. The narrow cylindrical ... quick and secure attachment to the ... Epilepsy electrode designs, they are available ...
Medicine Products: